Psilocybin Receives FDA Breakthrough Treatment Designation
The FDA will work to expedite the development and review of the drug so it can get to patients as soon as possible.
The FDA will work to expedite the development and review of the drug so it can get to patients as soon as possible.
The metabolism of psilocybin and psilocin is often cited. But, the supporting data are seldom discussed.
Psilocybin is showing promise for neuroregeneration and motor recovery in methods of treating phantom pain.
Recent studies on the biosynthesis of psilocybin provide an answer to this age-old question.
Researchers measured the effects of psilocybin in depressed people by comparing brain scan data.
New research examines the association between lifetime psychedelic use and intimate partner violence.
Psychedelic Science Review is working to bring cutting-edge science in the field of psychedelics to the public in the most accessible, thorough and accurate way possible. Join our communities on Facebook, Twitter, LinkedIn and Instagram and share our content with your network to help us bring scientifically-backed information about psychedelics to the world.
NEW! Shop the PSR Supporter Store to show your support for psychedelic science.